Genetec EBIT

The latest EBIT for 4492.T is $820M as of June 2026. That compares with $560M in the prior-year period — up 45.7% year over year. That is below the sector sector average of $2.6T. Investors often review this figure alongside Genetec's historical trend and sector peers before judging valuation or financial health.

Over the past year, 4492.T's EBIT moved from $560M to $820M — a 45.7% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Genetec's operating scale or balance-sheet position.

Against its sector companies, 4492.T currently prints $820M for EBIT, while the sector average sits near $2.6T. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Genetec's growth, margins, and balance sheet.

A EBIT figure of $820M for 4492.T is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $2.6T. Explore the charts below for those layers of context.

After noting 4492.T's EBIT ($820M), review year-over-year change from $560M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.